EP3966560A4 - Continuous glucose monitoring trend-enabled dose calculator - Google Patents

Continuous glucose monitoring trend-enabled dose calculator Download PDF

Info

Publication number
EP3966560A4
EP3966560A4 EP20806308.1A EP20806308A EP3966560A4 EP 3966560 A4 EP3966560 A4 EP 3966560A4 EP 20806308 A EP20806308 A EP 20806308A EP 3966560 A4 EP3966560 A4 EP 3966560A4
Authority
EP
European Patent Office
Prior art keywords
glucose monitoring
continuous glucose
dose calculator
monitoring trend
enabled dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP20806308.1A
Other languages
German (de)
French (fr)
Other versions
EP3966560A1 (en
Inventor
Michael MENSINGER
Jasper Benke
Sean Saint
Jack Pryor
Angela GAETANO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Companion Medical Inc
Original Assignee
Companion Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Companion Medical Inc filed Critical Companion Medical Inc
Publication of EP3966560A1 publication Critical patent/EP3966560A1/en
Publication of EP3966560A4 publication Critical patent/EP3966560A4/en
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/60—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3546—Range
    • A61M2205/3561—Range local, e.g. within room or hospital
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502—User interfaces, e.g. screens or keyboards
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2209/00—Ancillary equipment
    • A61M2209/01—Remote controllers for specific apparatus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nutrition Science (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
EP20806308.1A 2019-05-10 2020-05-08 Continuous glucose monitoring trend-enabled dose calculator Pending EP3966560A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962846397P 2019-05-10 2019-05-10
PCT/US2020/032233 WO2020231866A1 (en) 2019-05-10 2020-05-08 Continuous glucose monitoring trend-enabled dose calculator

Publications (2)

Publication Number Publication Date
EP3966560A1 EP3966560A1 (en) 2022-03-16
EP3966560A4 true EP3966560A4 (en) 2023-01-25

Family

ID=73289248

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20806308.1A Pending EP3966560A4 (en) 2019-05-10 2020-05-08 Continuous glucose monitoring trend-enabled dose calculator

Country Status (4)

Country Link
US (1) US20220211944A1 (en)
EP (1) EP3966560A4 (en)
CN (1) CN114144665A (en)
WO (1) WO2020231866A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210137427A1 (en) * 2019-11-13 2021-05-13 Insulet Corporation Adaptive duration of insulin action for use in insulin on board calculations
CA204308S (en) * 2020-12-21 2023-08-21 Hoffmann La Roche Display screen with graphical user interface
WO2023235866A2 (en) * 2022-06-03 2023-12-07 Bigfoot Biomedical, Inc. Medication delivery devices, systems and methods
CN117899295A (en) * 2022-10-19 2024-04-19 山东硅基算力科技有限公司 Method for obtaining a base dose of fluid and related devices and systems

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140309615A1 (en) * 2013-04-16 2014-10-16 Bryan Mazlish Discretionary insulin delivery systems and methods
US20170220751A1 (en) * 2016-02-01 2017-08-03 Dexcom, Inc. System and method for decision support using lifestyle factors
US20180200434A1 (en) * 2017-01-13 2018-07-19 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US20180353698A1 (en) * 2017-06-09 2018-12-13 Companion Medical, Inc. Intelligent medication delivery systems and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9901677B2 (en) * 2012-10-16 2018-02-27 Bigfoot Biomedical, Inc. Infusion pump system and methods
US9867937B2 (en) * 2013-09-06 2018-01-16 Tandem Diabetes Care, Inc. System and method for mitigating risk in automated medicament dosing
EP3694583A4 (en) * 2017-10-12 2021-08-04 Companion Medical, Inc. Intelligent medication delivery systems and methods for dose recommendation and management

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140309615A1 (en) * 2013-04-16 2014-10-16 Bryan Mazlish Discretionary insulin delivery systems and methods
US20170220751A1 (en) * 2016-02-01 2017-08-03 Dexcom, Inc. System and method for decision support using lifestyle factors
US20180200434A1 (en) * 2017-01-13 2018-07-19 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US20180353698A1 (en) * 2017-06-09 2018-12-13 Companion Medical, Inc. Intelligent medication delivery systems and methods

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "Glycemic index", WIKIPEDIA, 29 March 2019 (2019-03-29), pages 1 - 10, XP093008144, Retrieved from the Internet <URL:https://en.wikipedia.org/w/index.php?title=Glycemic_index&oldid=889979172> [retrieved on 20221214] *
FOSTER-POWELL K ET AL: "International table of glycemic index and glycemic load values: 2002", AMERICAN JOURNAL OF CLINICAL NUTRITION,, vol. 76, no. 1, 1 July 2002 (2002-07-01), pages 5 - 56, XP002369785, ISSN: 0002-9165 *
See also references of WO2020231866A1 *
ZEEVI DAVID ET AL: "Personalized Nutrition by Prediction of Glycemic Responses. Article plus Supplemental Information.", CELL, vol. 163, no. 5, 19 November 2015 (2015-11-19), Amsterdam NL, pages 1079 - 1094, XP055963631, ISSN: 0092-8674, Retrieved from the Internet <URL:https://ars.els-cdn.com/content/image/1-s2.0-S0092867415014816-mmc3.pdf> DOI: 10.1016/j.cell.2015.11.001 *

Also Published As

Publication number Publication date
CN114144665A (en) 2022-03-04
EP3966560A1 (en) 2022-03-16
US20220211944A1 (en) 2022-07-07
WO2020231866A1 (en) 2020-11-19

Similar Documents

Publication Publication Date Title
EP3897366A4 (en) Intermittent monitoring
EP3831294A4 (en) Continuous glucose monitoring device
EP3966560A4 (en) Continuous glucose monitoring trend-enabled dose calculator
EP3337402A4 (en) Diabetes management therapy advisor
EP3389491A4 (en) Data backfilling for continuous glucose monitoring
EP3781147A4 (en) Glucose-responsive insulin
EP4069347A4 (en) Blood pumps
EP3773203A4 (en) Continuous glucose monitoring device
EP4066249A4 (en) Recommendations based on continuous glucose monitoring
EP3982829A4 (en) Infusion device for continuous glucose monitoring
EP3799758A4 (en) Shoe with counter
EP3911226A4 (en) System for measuring heart rate
EP3880064A4 (en) Non-invasive monitoring system
EP4026582A4 (en) Catheter
EP3942540A4 (en) Fall-protection system with monitoring system
EP3831302A4 (en) Body attachment unit for continuous glucose monitoring
EP3989709A4 (en) Temporal, irradiance-controlled photoacclimation
EP3996775A4 (en) Infusion unit
EP4017569A4 (en) Catheter management device
EP3906959A4 (en) Catheter
EP3838145A4 (en) Oximeter
EP3601589A4 (en) Continuous glucose monitoring using an fad-dependent glucose dehydrogenase
EP3968521A4 (en) Counter unit
EP4010051A4 (en) Syringe
EP4011930A4 (en) Prepreg

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20211206

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20230102

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 27/26 20060101ALI20221220BHEP

Ipc: G16H 20/60 20180101ALI20221220BHEP

Ipc: G16H 20/17 20180101AFI20221220BHEP